Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease.

Jones RB, Walsh M, Chaudhry AN, Smith KG, Jayne DR.

Clin Kidney J. 2014 Dec;7(6):562-8. doi: 10.1093/ckj/sfu096. Epub 2014 Sep 16.

2.

Granulomatosis with polyangiitis (Wegener's): impact of maintenance therapy duration.

Springer J, Nutter B, Langford CA, Hoffman GS, Villa-Forte A.

Medicine (Baltimore). 2014 Mar;93(2):82-90. doi: 10.1097/MD.0000000000000020.

3.

Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study.

Chaigne B, Gatault P, Darrouzain F, Barbet C, Degenne D, François M, Szymanski P, Rabot N, Golea G, Diot E, Maillot F, Lebranchu Y, Nivet H, Paintaud G, Halimi JM, Guillevin L, Büchler M.

Clin Exp Immunol. 2014 May;176(2):172-9. doi: 10.1111/cei.12246.

4.

Progress in treatment of ANCA-associated vasculitis.

Smith RM, Jones RB, Jayne DR.

Arthritis Res Ther. 2012 Apr 30;14(2):210. doi: 10.1186/ar3797. Review.

5.

Immunotherapy of systemic sclerosis.

Manno R, Boin F.

Immunotherapy. 2010 Nov;2(6):863-78. doi: 10.2217/imt.10.69. Review.

6.

Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis.

Sam WJ, Joy MS.

Ther Drug Monit. 2010 Oct;32(5):594-605. doi: 10.1097/FTD.0b013e3181ee52e2.

7.

Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.

Silva F, Specks U, Kalra S, Hogan MC, Leung N, Sethi S, Fervenza FC.

Clin J Am Soc Nephrol. 2010 Mar;5(3):445-53. doi: 10.2215/CJN.06010809. Epub 2010 Jan 21.

8.

Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis.

Joy MS, Hilliard T, Hu Y, Hogan SL, Wang J, Falk RJ, Smith PC.

Ann Pharmacother. 2009 Jun;43(6):1020-7. doi: 10.1345/aph.1L699. Epub 2009 Jun 2.

9.

Mycophenolate mofetil for myasthenia gravis: a clear and present controversy.

Heatwole C, Ciafaloni E.

Neuropsychiatr Dis Treat. 2008 Dec;4(6):1203-9.

10.

Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist.

Papiris SA, Manali ED, Kalomenidis I, Kapotsis GE, Karakatsani A, Roussos C.

Crit Care. 2007;11(3):213. Review.

11.

Pulmonary vasculitis.

Brown KK.

Proc Am Thorac Soc. 2006;3(1):48-57. Review.

12.

Wegener's granulomatosis: current and upcoming therapies.

Langford CA.

Arthritis Res Ther. 2003;5(4):180-91. Epub 2003 May 29. Review.

Supplemental Content

Support Center